Montis Biosciences
Gaston Geenslaan 1
3001 Leuven
BE
Montis Biosciences
Foundation date
19/07/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Montis Biosciences’ mission is to therapeutically exploit cellular interactions between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors.
Montis Biociences was established based on the foundational science from the laboratories of Prof. Peter Carmeliet and Massimiliano Mazzone (VIB-KU Leuven), and is backed by an international syndicate of investors.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
0512 '23
The GxP Academy: Sterilisatie Validatie
Event by: Advipro
Latest news
More news-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
-
Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer
Wednesday November 29th 2023
Read more
-
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Wednesday November 29th 2023
Read more
Jobs
More jobs-
03/12/23
Limburg
PhD position in the field of neuroimmunology, mouse modelling and induced pluripotent stem cells
Permanent
VIB -
-
01/12/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders
Sales Engineer Belgium
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator